N/A
Completed N=7
Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence
Source: ClinicalTrials.gov NCT01770691 ↗Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcomePrimary: Mean Percentage of Pad Weight Gain (PWG) Change — 90.8; 98.5; 99.3; 89.3 Mean percentage of PWG change
Summary
Stress urinary incontinence (SUI) is most prevalent among women. SUI is characterized by loss of urine from increased abdominal pressures caused by coughing, laughing, sneezing, running, lifting or walking. SUI cause women to avoid routine physical activities, thus detracting significantly from their quality of life.
The purpose of this study is to evaluate the performance of new designs of the TIPI device, a conservative, disposable, treatment for temporary management of SUI.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Percentage of Pad Weight Gain (PWG) Change |
90.8; 98.5; 99.3; 89.3 | — |
Eligibility Criteria
Inclusion Criteria
- Females aged 18 to 60 years
- Had ≥ 1 deliveries
- Suffering from genuine stress urinary incontinence confirmed by urodynamic testing (Urodynamic stress urinary incontinence) and normal voiding without abnormal residual urine
- Baseline PWG (no usage of TIPI device) ≥ 6gr/8hrs
- Average reduction of urinary incontinence of at least 70% following 3 days usage of the cleared TIPI G3 device
- The patient has the ability to understand the nature of the study and give her consent by signing a written informed consent form.
- Successful experience with the use of vaginal tampons
- Willing to undergo urodynamic investigation
- Normal pap smear within past 24 months
- Patient is able and agrees to arrive to the study site area for a period of about 4-6 hours during 6-12 non consequent study days.
Exclusion Criteria
- Patient is pregnant, or suspected to be pregnant or is planning to be pregnant during the course of the study
- Patients with present or suspected urinary infection
- Patients with present or suspected vaginal infection
- Severely atrophic vagina
- Women who did not manage to insert a vaginal tampon, for any reason, in the past
- Abnormal vaginal bleeding
- Patient is currently participating in another clinical study that may directly or indirectly affect the results of this study
- Was/is being treated for urinary incontinence by other means such as medications, surgical intervention etc. that might influence study results
- Vaginal wall prolapse of any type reaching the level of the introitus (grade 2)
- Co-morbid condition(s) that could limit the patient's ability to participate in the study, or impact the scientific integrity of the study
Data sourced from ClinicalTrials.gov (NCT01770691). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.